Author: Ken Dropiewski

Fujifilm Presents Award-winning Synapse Enterprise Imaging Portfolio at HIMSS 2022

The Company celebrated its recognition for three Synapse solutions at KLAS Research’s 2022 Best In KLAS® Show Lexington, Mass., March 15, 2022 (GLOBE NEWSWIRE) — March 15, 2022 – Booth 3947 – FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, is showcasing its award-winning Synapse Enterprise Imaging portfolio […]

LimFlow Completes Enrollment in PROMISE II U.S. Pivotal Trial of Breakthrough Device Designed to Prevent Amputations in No-Option Patients With Chronic Limb-Threatening Ischemia

PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has completed patient enrollment in the PROMISE II pivotal trial of the LimFlow System. The LimFlow System is designed […]

Fist Assist Devices, LLC Announces Australian Distribution Deal and Sales Launch

Regional Health Care Group Selected For Commercialization in Australian Market. LAS VEGAS–(BUSINESS WIRE)–Fist Assist Devices, LLC, announces a three-year affiliation with Regional Health Care Group to commercialize and launch sales of the Fist Assist Model FA-1 device in Australia and New Zealand. The Fist Assist Model FA-1 is a wearable, […]

Evidation, VA Collaborate to Enroll Veterans in Personalized Heart Health Program

App-based program was co-developed by Evidation and the American College of Cardiology WASHINGTON & SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on […]

The Vascular Care Group Welcomes Nationally Recognized Vein Expert Dr. Harold J. Welch

Decorated physician brings 30+ years of experience to patients on Cape Cod HYANNIS, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Harold J. Welch, MD, FACS, RVT, RPVI has recently joined the Hyannis, […]

iRhythm® Technologies Announces Kevin King to Retire from Board of Directors

SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022. Mr. King joined the iRhythm Board in […]

Philips introduces new cloud-enabled enterprise imaging informatics and analytics solutions at HIMSS22

Philips advances precision care with new releases of HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge   Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference […]

NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System

ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study […]

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first patient has been enrolled in the quadruple-blinded sham-controlled […]

Stéphane Cohen Joins Quantum Genomics as Director of Global Operations

PARIS, March 14, 2022 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat resistant/hard-to-treat hypertension and heart failure, announces that Stéphane Cohen, a pharmacist and ESSEC graduate, is joining the team as Director […]